[Gd@C(82)(OH)(22)](n) Nanoparticles Induce Dendritic Cell Maturation and Activate Th1 Immune Responses

Overview

Journal ACS Nano

Publisher American Chemical Society

Specialty Biotechnology

Date 2010 Feb 4

PMID 20121217

Citations 36

Authors

De Yang

Yuliang Zhao

Hua Guo

Yana Li

Poonam Tewary

Gengmei Xing

Wei Hou

Joost J Oppenheim

Ning Zhang

Affiliations

Soon will be listed here.

Abstract

Dendritic cells play a pivotal role in host immune defense, such as elimination of foreign pathogen and inhibition of tumorigenesis. In this paper, we report that [Gd@C(82)(OH)(22)](n) could induce phenotypic maturation of dendritic cells by stimulating DC production of cytokines including IL-12p70, upregulating DC co-stimulatory (CD80, CD83, and CD86) and MHC (HLA-A,B,C and HLA-DR) molecules, and switching DCs from a CCL5-responsive to a CCL19-responsive phenotype. We found that [Gd@C(82)(OH)(22)](n) can induce dendritic cells to become functionally mature as illustrated by their capacity to activate allogeneic T cells. Mice immunized with ovalbumin in the presence of [Gd@C(82)(OH)(22)](n) exhibit enhanced ovalbumin-specific Th1-polarized immune response as evidenced by the predominantly increased production of IFNgamma, IL-1beta, and IL-2. The [Gd@C(82)(OH)(22)](n) nanoparticle is a potent activator of dendritic cells and Th1 immune responses. These new findings also provide a rational understanding of the potent anticancer activities of [Gd@C(82)(OH)(22)](n) nanoparticles reported previously.

Citing Articles

Fullerene Derivatives for Tumor Treatment: Mechanisms and Application.

Hou W, Shen L, Zhu Y, Wang X, Du T, Yang F Int J Nanomedicine. 2024; 19:9771-9797.

PMID: 39345909 PMC: 11430870. DOI: 10.2147/IJN.S476601.

Iron Oxide Nanoparticles Inhibit Tumor Progression and Suppress Lung Metastases in Mouse Models of Breast Cancer.

Korangath P, Jin L, Yang C, Healy S, Guo X, Ke S ACS Nano. 2024; 18(15):10509-10526.

PMID: 38564478 PMC: 11025112. DOI: 10.1021/acsnano.3c12064.

Oral Immunotherapy Reshapes Intestinal Immunosuppression via Metabolic Reprogramming to Enhance Systemic Anti-Tumor Immunity.

Cao X, Xu Y, Zhou C, Huo J, Su S, Liu L Adv Sci (Weinh). 2023; 10(35):e2302910.

PMID: 37884486 PMC: 10724426. DOI: 10.1002/advs.202302910.

Insights into the toxicological effects of nanomaterials on atherosclerosis: mechanisms involved and influence factors.

Chen S, Su Y, Zhang M, Zhang Y, Xiu P, Luo W J Nanobiotechnology. 2023; 21(1):140.

PMID: 37118804 PMC: 10148422. DOI: 10.1186/s12951-023-01899-y.

Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review.

Zhao X, Amevor F, Xue X, Wang C, Cui Z, Dai S J Nanobiotechnology. 2023; 21(1):121.

PMID: 37029392 PMC: 10081370. DOI: 10.1186/s12951-023-01876-5.

References

Dugan L, Lovett E, Quick K, Lotharius J, Lin T, OMalley K . Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord. 2001; 7(3):243-246. DOI: 10.1016/s1353-8020(00)00064-x. View

Dugan L, Gabrielsen J, Yu S, Lin T, Choi D . Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis. 1996; 3(2):129-35. DOI: 10.1006/nbdi.1996.0013. View

Mikawa M, Kato H, Okumura M, Narazaki M, Kanazawa Y, Miwa N . Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug Chem. 2001; 12(4):510-4. DOI: 10.1021/bc000136m. View

Wharton T, Wilson L . Highly-iodinated fullerene as a contrast agent for X-ray imaging. Bioorg Med Chem. 2002; 10(11):3545-54. DOI: 10.1016/s0968-0896(02)00252-3. View

Sugai T, Mori M, Nakazawa M, Ichino M, Naruto T, Kobayashi N . A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine. Vaccine. 2005; 23(46-47):5450-6. DOI: 10.1016/j.vaccine.2004.09.041. View

Tang J, Xing G, Zhao F, Yuan H, Zhao Y . Modulation of structural and electronic properties of fullerene and metallofullerenes by surface chemical modifications. J Nanosci Nanotechnol. 2007; 7(4-5):1085-101. DOI: 10.1166/jnn.2007.301. View

Fifis T, Gamvrellis A, Crimeen-Irwin B, Pietersz G, Li J, Mottram P . Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J Immunol. 2004; 173(5):3148-54. DOI: 10.4049/jimmunol.173.5.3148. View

Schinazi R, Sijbesma R, Srdanov G, Hill C, Wudl F . Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene. Antimicrob Agents Chemother. 1993; 37(8):1707-10. PMC: 188048. DOI: 10.1128/AAC.37.8.1707. View

Bianco A, Da Ros T, Prato M, Toniolo C . Fullerene-based amino acids and peptides. J Pept Sci. 2001; 7(4):208-19. DOI: 10.1002/psc.313. View

10.

Uto T, Wang X, Sato K, Haraguchi M, Akagi T, Akashi M . Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol. 2007; 178(5):2979-86. DOI: 10.4049/jimmunol.178.5.2979. View

11.

Elamanchili P, Diwan M, Cao M, Samuel J . Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine. 2004; 22(19):2406-12. DOI: 10.1016/j.vaccine.2003.12.032. View

12.

Bosi S, Da Ros T, Spalluto G, Prato M . Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem. 2003; 38(11-12):913-23. DOI: 10.1016/j.ejmech.2003.09.005. View

13.

Akasaka T, Kono T, Takematsu Y, Nikawa H, Nakahodo T, Wakahara T . Does Gd@C82 have an anomalous endohedral structure? Synthesis and single crystal X-ray structure of the carbene adduct. J Am Chem Soc. 2008; 130(39):12840-1. DOI: 10.1021/ja802156n. View

14.

Pantarotto D, Tagmatarchis N, Bianco A, Prato M . Synthesis and biological properties of fullerene-containing amino acids and peptides. Mini Rev Med Chem. 2004; 4(7):805-14. View

15.

Kurosaka K, Chen Q, Yarovinsky F, Oppenheim J, Yang D . Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol. 2005; 174(10):6257-65. DOI: 10.4049/jimmunol.174.10.6257. View

16.

Tegos G, Demidova T, Arcila-Lopez D, Lee H, Wharton T, Gali H . Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol. 2005; 12(10):1127-35. PMC: 3071678. DOI: 10.1016/j.chembiol.2005.08.014. View

17.

Cagle D, Kennel S, Mirzadeh S, Alford J, Wilson L . In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc Natl Acad Sci U S A. 1999; 96(9):5182-7. PMC: 21838. DOI: 10.1073/pnas.96.9.5182. View

18.

Liu Y, Jiao F, Qiu Y, Li W, Lao F, Zhou G . The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity. Biomaterials. 2009; 30(23-24):3934-45. DOI: 10.1016/j.biomaterials.2009.04.001. View

19.

Chaput N, Conforti R, Viaud S, Spatz A, Zitvogel L . The Janus face of dendritic cells in cancer. Oncogene. 2008; 27(45):5920-31. DOI: 10.1038/onc.2008.270. View

20.

Mashino T, Shimotohno K, Ikegami N, Nishikawa D, Okuda K, Takahashi K . Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives. Bioorg Med Chem Lett. 2005; 15(4):1107-9. DOI: 10.1016/j.bmcl.2004.12.030. View